ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

ARIEL DURAN MONDRAGON MD

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,415Medicare Part D Prescriptions Filled, Including Refills

Rank: 61 out of 457

$1.03M Total Retail Price of All Prescriptions

Rank: 43 out of 457

707 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
94% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

3% of this provider’s 707 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

2% of this provider’s 10,282 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

36% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$77 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
OMEPRAZOLE 624 491 1 1
METFORMIN HCL 457 375 2 6
LISINOPRIL 414 317 3 3
IBUPROFEN 401 284 4 14
SIMVASTATIN 341 277 5 2
NEXIUM 318 208 6 12
AMLODIPINE BESYLATE 297 245 7 4
LEVOTHYROXINE SODIUM 288 261 8 5
ATENOLOL 272 221 9 11
METOPROLOL TARTRATE 266 233 10 7
LIDODERM 242 184 11 31
CRESTOR 232 179 12 9
PLAVIX 214 188 13 24
LOVAZA 191 153 14 50
SINGULAIR 186 137 15 43
ADVAIR DISKUS 177 146 16 27
HYDROCHLOROTHIAZIDE 177 129 16 8
CLOPIDOGREL 170 151 18 19
CELEBREX 168 137 19 53
TRAMADOL HCL 159 123 20 26
DIOVAN 157 123 21 30
GABAPENTIN 149 100 22 15
GLIPIZIDE 148 130 23 42
DICLOFENAC SODIUM 143 109 24 49
ALENDRONATE SODIUM 141 130 25 16
VOLTAREN 135 120 26 34
FUROSEMIDE 131 101 27 10
NOVOLIN 70-30 130 100 28 113
INSULIN SYRINGE 114 80 29 79
LOSARTAN POTASSIUM 105 93 30 18
RANITIDINE HCL 98 85 31 17
NAMENDA 98 82 31 32
SURE COMFORT 96 96 33 103
ZOLPIDEM TARTRATE 95 55 34 13
PROAIR HFA 95 46 34 66
LANTUS 93 83 36 56
ATORVASTATIN CALCIUM 88 65 37 33
DONEPEZIL HCL 88 87 37 22
ALCOHOL PREP PADS 83 74 39 323
MECLIZINE HCL 80 74 40 55
LISINOPRIL-HYDROCHLOROTHIAZIDE 80 42 40 37
DIOVAN HCT 80 59 40 51
MONTELUKAST SODIUM 78 59 43 86
GLYBURIDE-METFORMIN HCL 77 53 R 44 70
MEGESTROL ACETATE 74 49 R 45 94
ENALAPRIL MALEATE 73 60 46 35
FLUTICASONE PROPIONATE 69 45 47 40
TRIAMCINOLONE ACETONIDE 67 58 48 132
NAPROXEN 64 54 49 65
CARVEDILOL 63 47 50 20
CYCLOBENZAPRINE HCL 63 48 R 50 99
METOPROLOL SUCCINATE 62 59 52 21
ACTOS 62 50 52 105
TAMSULOSIN HCL 60 52 54 36
DICYCLOMINE HCL 60 37 54 115
MELOXICAM 60 39 54 41
LYRICA 58 44 57 77
COMBIVENT 57 37 58 133
ALLOPURINOL 56 51 59 47
HYDROXYZINE HCL 55 39 R 60 199
NASONEX 53 24 61 129
CLOTRIMAZOLE-BETAMETHASONE 51 23 62 60
CYMBALTA 50 45 63 97
CLONIDINE HCL 50 35 63 52
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 28, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.